Additional File 2: Table S2. of CRISPR/Cas9-mediated Targeted Chromosome Elimination

Erwei Zuo,Xiaona Huo,Xuan Yao,Xin Hu,Yidi Sun,Jianhang Yin,Bingbing He,Xing Wang,Linqi Shi,Jie Ping,Wenxia Yu,Weiwen Ying,Wu Wei,Wenjia Liu,Tao Cheng,Yixue Li,Jiazhi Hu,Hui Yang

DOI: https://doi.org/10.6084/m9.figshare.5697121

2017-01-01

Abstract:Unique and multiple repeated sequences for targeting by a single specific sgRNA. (XLSX 9524 kb)

What problem does this paper attempt to address?

Targeted Mutagenesis of Duplicated Genes in Caenorhabditis Elegans Using CRISPR-Cas9

Suhong Xu,Zhiping Wang,Kyung Won Kim,Yishi Jin,Andrew D. Chisholm

DOI: https://doi.org/10.1016/j.jgg.2015.11.004

2016-01-01

Abstract:CRISPR（clustered regularly interspaced short palindromic repeats）-Cas9-based genome editing has revolutionized functional genomics in many biological research fields.The specificity and potency of CRISPR-Cas9 genome editing make it ideal for investigating the function of genes in vivo(Hsu
CRISPR/Cas9 Targeting Events Cause Complex Deletions and Insertions at 17 Sites in the Mouse Genome

Ha Youn Shin,Chaochen Wang,Hye Kyung Lee,Kyung Hyun Yoo,Xianke Zeng,Tyler Kuhns,Chul Min Yang,Teresa Mohr,Chengyu Liu,Lothar Hennighausen

DOI: https://doi.org/10.1038/ncomms15464

IF: 16.6

2017-01-01

Nature Communications

Abstract:Although CRISPR/Cas9 genome editing has provided numerous opportunities to interrogate the functional significance of any given genomic site, there is a paucity of data on the extent of molecular scars inflicted on the mouse genome. Here we interrogate the molecular consequences of CRISPR/Cas9-mediated deletions at 17 sites in four loci of the mouse genome. We sequence targeted sites in 632 founder mice and analyse 54 established lines. While the median deletion size using single sgRNAs is 9 bp, we also obtain large deletions of up to 600 bp. Furthermore, we show unreported asymmetric deletions and large insertions of middle repetitive sequences. Simultaneous targeting of distant loci results in the removal of the intervening sequences. Reliable deletion of juxtaposed sites is only achieved through two-step targeting. Our findings also demonstrate that an extended analysis of F1 genotypes is required to obtain conclusive information on the exact molecular consequences of targeting events.
[Optimization of CRISPR/Cas9-based multiplex base editing in Corynebacterium glutamicum].

Hui Lu,Qi Zhang,Sili Yu,Yu Wang,Ming Kang,Shuangyan Han,Ye Liu,Meng Wang

DOI: https://doi.org/10.13345/j.cjb.210109

2022-01-01

Abstract:As a new CRISPR/Cas-derived genome engineering technology, base editing combines the target specificity of CRISPR/Cas and the catalytic activity of nucleobase deaminase to install point mutations at target loci without generating DSBs, requiring exogenous template, or depending on homologous recombination. Recently, researchers have developed a variety of base editing tools in the important industrial strain Corynebacterium glutamicum, and achieved simultaneous editing of two and three genes. However, the multiplex base editing based on CRISPR/Cas9 is still limited by the complexity of multiple sgRNAs, interference of repeated sequence and difficulty of target loci replacement. In this study, multiplex base editing in C. glutamicum was optimized by the following strategies. Firstly, the multiple sgRNA expression cassettes based on individual promoters/terminators was optimized. The target loci can be introduced and replaced rapidly by using a template plasmid and Golden Gate method, which also avoids the interference of repeated sequence. Although the multiple sgRNAs structure is still complicated, the editing efficiency of this strategy is the highest. Then, the multiple gRNA expression cassettes based on Type Ⅱ CRISPR crRNA arrays and tRNA processing were developed. The two strategies only require one single promoter and terminator, and greatly simplify the structure of the expression cassette. Although the editing efficiency has decreased, both methods are still applicable. Taken together, this study provides a powerful addition to the genome editing toolbox of C. glutamicum and facilitates genetic modification of this strain.
Additional File 13 of Exploration of the Regulatory Relationship Between KRAB-Zfp Clusters and Their Target Transposable Elements Via a Gene Editing Strategy at the Cluster Specific Linker-Associated Sequences by CRISPR-Cas9

Yang Zhang,Fei He,Yanning Zhang,Qian Dai,Qintong Li,Nan Jing,Ruidong Miao,Bo Cheng

DOI: https://doi.org/10.6084/m9.figshare.21541882

2022-01-01

Abstract:Additional file 13 Supplementary Table 5. sgRNA efficiency test in reporter system (raw data for Fig. 4B and D).
CRISPR/Cas9-mediated Targeted Chromosome Elimination.

Erwei Zuo,Xiaona Huo,Xuan Yao,Xinde Hu,Yidi Sun,Jianhang Yin,Bingbing He,Xing Wang,Linyu Shi,Jie Ping,Yu Wei,Wenqin Ying,Wei,Wenjia Liu,Cheng Tang,Yixue Li,Jiazhi Hu,Hui Yang

DOI: https://doi.org/10.1186/s13059-017-1354-4

IF: 17.906

2017-01-01

Genome Biology

Abstract:BACKGROUND:The CRISPR/Cas9 system has become an efficient gene editing method for generating cells carrying precise gene mutations, including the rearrangement and deletion of chromosomal segments. However, whether an entire chromosome could be eliminated by this technology is still unknown.RESULTS:Here we demonstrate the use of the CRISPR/Cas9 system to eliminate targeted chromosomes. Using either multiple cleavages induced by a single-guide RNA (sgRNA) that targets multiple chromosome-specific sites or a cocktail of multiple sgRNAs, each targeting one specific site, we found that a sex chromosome could be selectively eliminated in cultured cells, embryos, and tissues in vivo. Furthermore, this approach was able to produce a targeted autosome loss in aneuploid mouse embryonic stem cells with an extra human chromosome and human induced pluripotent stem cells with trisomy 21, as well as cancer cells.CONCLUSIONS:CRISPR/Cas9-mediated targeted chromosome elimination offers a new approach to develop animal models with chromosome deletions, and a potential therapeutic strategy for human aneuploidy diseases involving additional chromosomes.
Additional File 9 of Exploration of the Regulatory Relationship Between KRAB-Zfp Clusters and Their Target Transposable Elements Via a Gene Editing Strategy at the Cluster Specific Linker-Associated Sequences by CRISPR-Cas9

Yang Zhang,Fei He,Yanning Zhang,Qian Dai,Qintong Li,Nan Jing,Ruidong Miao,Bo Cheng

DOI: https://doi.org/10.6084/m9.figshare.21541951

2022-01-01

Abstract:Additional file 9 Supplementary Table 1. All mouse and human KRAB-ZFP genes (information for Fig. 1 A and S1A)
Harnessing accurate non-homologous end joining for efficient precise deletion in CRISPR/Cas9-mediated genome editing

Tao Guo,Yi-Li Feng,Jing-Jing Xiao,Qian Liu,Xiu-Na Sun,Ji-Feng Xiang,Na Kong,Si-Cheng Liu,Guo-Qiao Chen,Yue Wang,Meng-Meng Dong,Zhen Cai,Hui Lin,Xiu-Jun Cai,An-Yong Xie

DOI: https://doi.org/10.1186/s13059-018-1518-x

IF: 17.906

2018-01-01

Genome Biology

Abstract:Background Many applications of CRISPR/Cas9-mediated genome editing require Cas9-induced non-homologous end joining (NHEJ), which was thought to be error prone. However, with directly ligatable ends, Cas9-induced DNA double strand breaks may be repaired preferentially by accurate NHEJ. Results In the repair of two adjacent double strand breaks induced by paired Cas9-gRNAs at 71 genome sites, accurate NHEJ accounts for about 50% of NHEJ events. This paired Cas9-gRNA approach underestimates the level of accurate NHEJ due to frequent + 1 templated insertions, which can be avoided by the predefined Watson/Crick orientation of protospacer adjacent motifs (PAMs). The paired Cas9-gRNA strategy also provides a flexible, reporter-less approach for analyzing both accurate and mutagenic NHEJ in cells and in vivo, and it has been validated in cells deficient for XRCC4 and in mouse liver. Due to high frequencies of precise deletions of defined “3n”-, “3n + 1”-, or “3n + 2”-bp length, accurate NHEJ is used to improve the efficiency and homogeneity of gene knockouts and targeted in-frame deletions. Compared to “3n + 1”-bp, “3n + 2”-bp can overcome + 1 templated insertions to increase the frequency of out-of-frame mutations. By applying paired Cas9-gRNAs to edit MDC1 and key 53BP1 domains, we are able to generate predicted, precise deletions for functional analysis. Lastly, a Plk3 inhibitor promotes NHEJ with bias towards accurate NHEJ, providing a chemical approach to improve genome editing requiring precise deletions. Conclusions NHEJ is inherently accurate in repair of Cas9-induced DNA double strand breaks and can be harnessed to improve CRISPR/Cas9 genome editing requiring precise deletion of a defined length.
Cas9-Cleavage Sequences in Size-Reduced Plasmids Enhance Nonviral Genome Targeting of CARs in Primary Human T Cells.

Ruirui Jing,Peng Jiao,Jiangqing Chen,Xianhui Meng,Xiaoyan Wu,Yanting Duan,Kai Shang,Liling Qian,Yanjie Huang,Junwei Liu,Tao Huang,Jin,Wei Chen,Xun Zeng,Weiwei Yin,Xiaofei Gao,Chun Zhou,Michel Sadelain,Jie Sun

DOI: https://doi.org/10.1002/smtd.202100071

IF: 12.4

2021-01-01

Small Methods

Abstract:T cell genome editing holds great promise to advance a range of immunotherapies but is encumbered by the dependence on difficult-to-produce and expensive viral vectors. Here, small double-stranded plasmid DNA modified to mediate high-efficiency homologous recombination is designed. The resulting chimeric antigen receptor (CAR)-T cells display a similar phenotype, transcriptional profile, and in vivo potency to CAR-T cells generated using adeno-associated viral vector. This method should simplify and accelerate the use of precision engineering to produce edited T cells for research and clinical purposes.
Additional File 5 of Engineering CRISPR/Cas9 to Mitigate Abundant Host Contamination for 16S Rrna Gene-Based Amplicon Sequencing

Luyang Song,Kabin Xie

DOI: https://doi.org/10.6084/m9.figshare.12422384

2020-01-01

Abstract:Additional file 5: Table S7. Summary of 515F-806R amplicon result. Table S8. Abundance of bacterial OTUs detected in leaf 515F-806R amplicons.
CRISPR MultiTargeter: A Web Tool to Find Common and Unique CRISPR Single Guide RNA Targets in a Set of Similar Sequences

Sergey V. Prykhozhij,Vinothkumar Rajan,Daniel Gaston,Jason N. Berman

DOI: https://doi.org/10.1371/journal.pone.0119372

IF: 3.7

2015-03-05

PLoS ONE

Abstract:Genome engineering has been revolutionized by the discovery of clustered regularly interspaced palindromic repeats (CRISPR) and CRISPR-associated system genes (Cas) in bacteria. The type IIB Streptococcus pyogenes CRISPR/Cas9 system functions in many species and additional types of CRISPR/Cas systems are under development. In the type II system, expression of CRISPR single guide RNA (sgRNA) targeting a defined sequence and Cas9 generates a sequence-specific nuclease inducing small deletions or insertions. Moreover, knock-in of large DNA inserts has been shown at the sites targeted by sgRNAs and Cas9. Several tools are available for designing sgRNAs that target unique locations in the genome. However, the ability to find sgRNA targets common to several similar sequences or, by contrast, unique to each of these sequences, would also be advantageous. To provide such a tool for several types of CRISPR/Cas system and many species, we developed the CRISPR MultiTargeter software. Similar DNA sequences in question are duplicated genes and sets of exons of different transcripts of a gene. Thus, we implemented a basic sgRNA target search of input sequences for single-sgRNA and two-sgRNA/Cas9 nickase targeting, as well as common and unique sgRNA target searches in 1) a set of input sequences; 2) a set of similar genes or transcripts; or 3) transcripts a single gene. We demonstrate potential uses of the program by identifying unique isoform-specific sgRNA sites in 71% of zebrafish alternative transcripts and common sgRNA target sites in approximately 40% of zebrafish duplicated gene pairs. The design of unique targets in alternative exons is helpful because it will facilitate functional genomic studies of transcript isoforms. Similarly, its application to duplicated genes may simplify multi-gene mutational targeting experiments. Overall, this program provides a unique interface that will enhance use of CRISPR/Cas technology.

multidisciplinary sciences
Multiplex CRISPR/Cas9-based genome engineering enhanced by Drosha-mediated sgRNA-shRNA structure

Qiang Yan,Kun Xu,Jiani Xing,Tingting Zhang,Xin Wang,Zehui Wei,Chonghua Ren,Zhongtian Liu,Simin Shao,Zhiying Zhang

DOI: https://doi.org/10.1038/srep38970

IF: 4.6

2016-01-01

Scientific Reports

Abstract:The clustered regularly interspaced short palindromic repeats (CRISPR) system has recently been developed into a powerful genome-editing technology, as it requires only two key components (Cas9 protein and sgRNA) to function and further enables multiplex genome targeting and homology-directed repair (HDR) based precise genome editing in a wide variety of organisms. Here, we report a novel and interesting strategy by using the Drosha-mediated sgRNA-shRNA structure to direct Cas9 for multiplex genome targeting and precise genome editing. For multiplex genome targeting assay, we achieved more than 9% simultaneous mutant efficiency for 3 genomic loci among the puromycin-selected cell clones. By introducing the shRNA against DNA ligase IV gene ( LIG4 ) into the sgRNA-shRNA construct, the HDR-based precise genome editing efficiency was improved as more than 2-fold. Our works provide a useful tool for multiplex and precise genome modifying in mammalian cells.
Additional File 2 of SWISS: Multiplexed Orthogonal Genome Editing in Plants with a Cas9 Nickase and Engineered CRISPR RNA Scaffolds

Chao Li,Yuan Zong,Shuai Jin,Haocheng Zhu,Dexing Lin,Shengnan Li,Jian Qiu,Yanpeng Wang,Caixia Gao

DOI: https://doi.org/10.6084/m9.figshare.12494756.v1

2020-01-01

Abstract:Additional file 2: Sequences S1. DNA sequences of the OsU3 and TaU6 promoters used in this study. Sequences S2. DNA sequences of sgRNA, esgRNA, and scRNAs used in this study. Sequences S3. DNA sequences of the modules composed of PBEcs and PABEcs used in this study. Sequences S4. DNA sequences of templates for assemble multiple sgRNAs used in this study. Sequences S5. DNA sequences of SWISSv2/v3 and SWISSv2/v3-NG used in this study.
Additional File 10 of Exploration of the Regulatory Relationship Between KRAB-Zfp Clusters and Their Target Transposable Elements Via a Gene Editing Strategy at the Cluster Specific Linker-Associated Sequences by CRISPR-Cas9

Yang Zhang,Fei He,Yanning Zhang,Qian Dai,Qintong Li,Nan Jing,Ruidong Miao,Bo Cheng

DOI: https://doi.org/10.6084/m9.figshare.21541864

2022-01-01

Abstract:Additional file 10 Supplementary Table 2. The identity and frequency of all types of fingerprints in mouse KRAB-ZFP-associated ZnFs (information for Supplementary Fig. 3).
Cas9 Exo-Endonuclease Eliminates Chromosomal Translocations During Genome Editing

Jianhang Yin,Rusen Lu,Changchang Xin,Yuhong Wang,Xinyu Ling,Dong Li,Weiwei Zhang,Mengzhu Liu,Wutao Xie,Lingyun Kong,Wen Si,Ping Wei,Bingbing Xiao,Hsiang-Ying Lee,Tao Liu,Jiazhi Hu

DOI: https://doi.org/10.1038/s41467-022-28900-w

IF: 16.6

2022-01-01

Nature Communications

Abstract:The mechanism underlying unwanted structural variations induced by CRISPR-Cas9 remains poorly understood, and no effective strategy is available to inhibit the generation of these byproducts. Here we find that the generation of a high level of translocations is dependent on repeated cleavage at the Cas9-targeting sites. Therefore, we employ a strategy in which Cas9 is fused with optimized TREX2 to generate Cas9TX, a Cas9 exo-endonuclease, which prevents perfect DNA repair and thereby avoids repeated cleavage. In comparison with CRISPR-Cas9, CRISPR-Cas9TX greatly suppressed translocation levels and enhanced the editing efficiency of single-site editing. The number of large deletions associated with Cas9TX was also reduced to very low level. The application of CRISPR-Cas9TX for multiplex gene editing in chimeric antigen receptor T cells nearly eliminated deleterious chromosomal translocations. We report the mechanism underlying translocations induced by Cas9, and propose a general strategy for reducing chromosomal abnormalities induced by CRISPR-RNA-guided endonucleases.
Dual Sgrnas Facilitate CRISPR/Cas9‐mediated Mouse Genome Targeting

Jiankui Zhou,Jianying Wang,Bin Shen,Li Chen,Yang Su,Jing Yang,Wensheng Zhang,Xuemei Tian,Xingxu Huang

DOI: https://doi.org/10.1111/febs.12735

2014-01-01

FEBS Journal

Abstract:The bacterial clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR‐associated 9 (Cas9) system is a versatile RNA‐guided mammalian genome modification system. One‐step generation of mouse genome targeting has been achieved by co‐microinjection of one‐cell stage embryos with Cas9 mRNA and small/single guide (sg)RNA. Many studies have focused on enhancing the efficiency of this system. In the present study, we report that simultaneous use of dual sgRNAs to target an individual gene significantly improved the Cas9‐mediated genome targeting with a bi‐allelic modification efficiency of up to 78%. We further observed that the target gene modifications were characterized by efficient germline transmission and site‐dependent off‐target effects, and also that the apolipoprotein E gene knockout‐mediated defects in blood biochemical parameters were recapitulated by CRISPR/Cas9‐mediated heritable gene modification. Our results provide a dual sgRNAs strategy to facilitate CRISPR/Cas9‐mediated mouse genome targeting.
Eliminating predictable DNA off-target effects of cytosine base editor by using dual guiders including sgRNA and TALE

Jizeng Zhou,Yang Liu,Yuhui Wei,Shuwen Zheng,Shixue Gou,Tao Chen,Yang Yang,Ting Lan,Min Chen,Yuan Liao,Quanjun Zhang,Chengcheng Tang,Yu Liu,Yunqin Wu,Xiaohua Peng,Minghui Gao,Junwei Wang,Kun Zhang,Liangxue Lai,Qingjian Zou

DOI: https://doi.org/10.1016/j.ymthe.2022.04.010

IF: 12.91

2022-04-01

Molecular Therapy

Abstract:Predictable DNA off-target effect is one of the major safety concerns for the application of cytosine base editors (CBEs). To eliminate Cas9-dependent DNA off-target effects, we designed a novel effective CBE system with dual guiders by combining CRISPR with transcription activator-like effector (TALE). In this system, Cas9 nickase (nCas9) and cytosine deaminase are guided to the same target site to conduct base editing by single-guide RNA (sgRNA) and TALE, respectively. However, if nCas9 is guided to a wrong site by sgRNA, it will not generate base editing due to the absence of deaminase. Similarly, when deaminase is guided to a wrong site by TALE, base editing will not occur due to the absence of single-stranded DNA. In this way, Cas9- and TALE-dependent DNA off-target effects could be completely eliminated. Furthermore, by fusing TALE with YE1, a cytidine deaminase with minimal Cas9-independent off-target effect, we established a novel CBE that could induce efficient C-to-T conversion without detectable Cas9- or TALE-dependent DNA off-target mutations.

genetics & heredity,medicine, research & experimental,biotechnology & applied microbiology
Precise large-fragment deletions in mammalian cells and mice generated by dCas9-controlled CRISPR/Cas3

Jinze Li,Ding Zhao,Tao Zhang,Haoyang Xiong,Mingyang Hu,Hongmei Liu,Feiyu Zhao,Xiaodi Sun,Peng Fan,Yuqiang Qian,Di Wang,Liangxue Lai,Tingting Sui,Zhanjun Li

DOI: https://doi.org/10.1126/sciadv.adk8052

IF: 13.6

2024-03-17

Science Advances

Abstract:Currently, the Cas9 and Cas12a systems are widely used for genome editing, but their ability to precisely generate large chromosome fragment deletions is limited. Type I-E CRISPR mediates broad and unidirectional DNA degradation, but controlling the size of Cas3-mediated DNA deletions has proven elusive thus far. Here, we demonstrate that the endonuclease deactivation of Cas9 (dCas9) can precisely control Cas3-mediated large-fragment deletions in mammalian cells. In addition, we report the elimination of the Y chromosome and precise retention of the Sry gene in mice using CRISPR/Cas3 and dCas9-controlled CRISPR/Cas3, respectively. In conclusion, dCas9-controlled CRISPR/Cas3-mediated precise large-fragment deletion provides an approach for establishing animal models by chromosome elimination. This method also holds promise as a potential therapeutic strategy for treating fragment mutations or human aneuploidy diseases that involve additional chromosomes.

multidisciplinary sciences
Mitigation of chromosome loss in clinical CRISPR-Cas9-engineered T cells

Connor A Tsuchida,Nadav Brandes,Raymund Bueno,Marena Trinidad,Thomas Mazumder,Bingfei Yu,Byungjin Hwang,Christopher Chang,Jamin Liu,Yang Sun,Caitlin R Hopkins,Kevin R Parker,Yanyan Qi,Laura Hofman,Ansuman T Satpathy,Edward A Stadtmauer,Jamie H D Cate,Justin Eyquem,Joseph A Fraietta,Carl H June,Howard Y Chang,Chun Jimmie Ye,Jennifer A Doudna,Connor A. Tsuchida,Caitlin R. Hopkins,Kevin R. Parker,Ansuman T. Satpathy,Edward A. Stadtmauer,Jamie H.D. Cate,Joseph A. Fraietta,Carl H. June,Howard Y. Chang,Jennifer A. Doudna

DOI: https://doi.org/10.1016/j.cell.2023.08.041

2023-10-05

Cell Journal

Abstract:Highlights • Cas9 genome editing in T cells results in unintended but targeted chromosome loss • Chromosome loss from T cell genome editing is generalizable across target sites • Cas9-induced chromosome loss persists for weeks in cultured T cells • A modified protocol mitigates chromosome loss in T cells used for a clinical trial Summary CRISPR-Cas9 genome editing has enabled advanced T cell therapies, but occasional loss of the targeted chromosome remains a safety concern. To investigate whether Cas9-induced chromosome loss is a universal phenomenon and evaluate its clinical significance, we conducted a systematic analysis in primary human T cells. Arrayed and pooled CRISPR screens revealed that chromosome loss was generalizable across the genome and resulted in partial and entire loss of the targeted chromosome, including in preclinical chimeric antigen receptor T cells. T cells with chromosome loss persisted for weeks in culture, implying the potential to interfere with clinical use. A modified cell manufacturing process, employed in our first-in-human clinical trial of Cas9-engineered T cells (NCT03399448), reduced chromosome loss while largely preserving genome editing efficacy. Expression of p53 correlated with protection from chromosome loss observed in this protocol, suggesting both a mechanism and strategy for T cell engineering that mitigates this genotoxicity in the clinic. Graphical abstract Download : Download high-res image (225KB) Download : Download full-size image

cell biology
Tandem Repeat Knockout Utilizing the CRISPR/Cas9 System in Human Cells.

Qingyan Lv,Liangxue Lai,Lin Yuan,Yuning Song,Tingting Sui,Zhanjun Li

DOI: https://doi.org/10.1016/j.gene.2016.02.013

IF: 3.913

2016-01-01

Gene

Abstract:Tandem repeats have been shown to cause human genetic diseases and contribute significantly to genome variation and instability. Although multi-sgRNAs mediated CRISPR/Cas9 system have used to generate regional deletions previously, in this study we explored a method of generating regional deletions of tandem repeats by taking advantage of the off-target effects of CRISPR/Cas9 in 293FT cells. Our results revealed that generation of large-fragment deletions of tandem repeats located in the MAGEL2 and XIST gene was possible. In summary, we have demonstrated that large-fragment deletions of tandem repeats can be achieved using a sgRNA-directed CRISPR/Cas9 system, facilitating the functional study of tandem repeats in future studies.
Abstract 3374: CRISPR/Cas9 Mediated Genome Editing Induces Exon Skipping by Alternative Splicing or Exon Deletion

Haiwei Mou,Jordan L. Smith,Lingtao Peng,Hao Yin,Jill Moore,Xiao‐Ou Zhang,Chun‐Qing Song,Ankur Sheel,Qiongqiong Wu,Deniz M. Özata,Yingxiang Li,Daniel G. Anderson,Charles P. Emerson,Melissa J. Moore,Zhiping Weng,Wen Xue

DOI: https://doi.org/10.1158/1538-7445.am2018-3374

IF: 11.2

2018-01-01

Cancer Research

Abstract:CRISPR is widely used to disrupt gene function by inducing small insertions and deletions. Here, we show that some single-guide RNAs (sgRNAs) can induce exon skipping or large genomic deletions that delete exons. For example, CRISPR-mediated editing of β-catenin exon 3, which encodes an autoinhibitory domain, induces partial skipping of the in-frame exon and nuclear accumulation of β-catenin. A single sgRNA can induce small insertions or deletions that partially alter splicing or unexpected larger deletions that remove exons. Exon skipping adds to the unexpected outcomes that must be accounted for, and perhaps taken advantage of, in CRISPR experiments. Citation Format: Haiwei Mou, Jordan Smith, Lingtao Peng, Hao Yin, Jill Moore, Xiao-Ou Zhang, Chunqing Song, Ankur Sheel, Qiongqiong Wu, Deniz Ozata, Yingxiang Li, Daniel Anderson, Charles Emerson, Melissa Moore, Zhiping Weng, Wen Xue. CRISPR/Cas9 mediated genome editing induces exon skipping by alternative splicing or exon deletion [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2018; 2018 Apr 14-18; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2018;78(13 Suppl):Abstract nr 3374.

Additional File 2: Table S2. of CRISPR/Cas9-mediated Targeted Chromosome Elimination

Targeted Mutagenesis of Duplicated Genes in Caenorhabditis Elegans Using CRISPR-Cas9

CRISPR/Cas9 Targeting Events Cause Complex Deletions and Insertions at 17 Sites in the Mouse Genome

[Optimization of CRISPR/Cas9-based multiplex base editing in Corynebacterium glutamicum].

Additional File 13 of Exploration of the Regulatory Relationship Between KRAB-Zfp Clusters and Their Target Transposable Elements Via a Gene Editing Strategy at the Cluster Specific Linker-Associated Sequences by CRISPR-Cas9

CRISPR/Cas9-mediated Targeted Chromosome Elimination.

Additional File 9 of Exploration of the Regulatory Relationship Between KRAB-Zfp Clusters and Their Target Transposable Elements Via a Gene Editing Strategy at the Cluster Specific Linker-Associated Sequences by CRISPR-Cas9

Harnessing accurate non-homologous end joining for efficient precise deletion in CRISPR/Cas9-mediated genome editing

Cas9-Cleavage Sequences in Size-Reduced Plasmids Enhance Nonviral Genome Targeting of CARs in Primary Human T Cells.

Additional File 5 of Engineering CRISPR/Cas9 to Mitigate Abundant Host Contamination for 16S Rrna Gene-Based Amplicon Sequencing

CRISPR MultiTargeter: A Web Tool to Find Common and Unique CRISPR Single Guide RNA Targets in a Set of Similar Sequences

Multiplex CRISPR/Cas9-based genome engineering enhanced by Drosha-mediated sgRNA-shRNA structure

Additional File 2 of SWISS: Multiplexed Orthogonal Genome Editing in Plants with a Cas9 Nickase and Engineered CRISPR RNA Scaffolds

Additional File 10 of Exploration of the Regulatory Relationship Between KRAB-Zfp Clusters and Their Target Transposable Elements Via a Gene Editing Strategy at the Cluster Specific Linker-Associated Sequences by CRISPR-Cas9

Cas9 Exo-Endonuclease Eliminates Chromosomal Translocations During Genome Editing

Dual Sgrnas Facilitate CRISPR/Cas9‐mediated Mouse Genome Targeting

Eliminating predictable DNA off-target effects of cytosine base editor by using dual guiders including sgRNA and TALE

Precise large-fragment deletions in mammalian cells and mice generated by dCas9-controlled CRISPR/Cas3

Mitigation of chromosome loss in clinical CRISPR-Cas9-engineered T cells

Tandem Repeat Knockout Utilizing the CRISPR/Cas9 System in Human Cells.

Abstract 3374: CRISPR/Cas9 Mediated Genome Editing Induces Exon Skipping by Alternative Splicing or Exon Deletion